Business
Grant of Options
EnSilica plc has granted options under its Long Term Incentive Plan 2022 to executive directors and senior management, with 2,166,000 options awarded to executive directors, including 1,212,000 to the CEO, 561,000 to the CFO, and 393,000 to the Chairman. These options vest based on demanding performance conditions related to adjusted EBITDA targets, requiring £10.0 million to £13.0 million for FY2029 or £12.0 million to £15.0 million for FY2030, and Total Shareholder Return targets with vesting commencing at 150 pence to 200 pence for FY2029 or 172 pence to 252 pence for FY2030. The exercise price for these options is 0.1 pence per share, and 50% of shares acquired upon vesting will be subject to a one-year holding period. Disclaimer*
About this update from Ensilica Plc
17 July 2026 EnSilica plc ("EnSilica" or the "Company") Grant of options to executive directors and management EnSilica (AIM: ENSI), a leading fabless microchip maker with a growing portfolio of reusable IP, serving the Space and Communications, Industrial, and Automotive markets, announces that the Company's Remuneration Committee has approved the grant of options over ordinary shares of 0.1p each in the Company ("Ordinary Shares") under the Company's Long Term Incentive Plan 2022 (the "LTIP") to the Company's Executive Directors and members of the senior management team (the "Options"). The Options are intended to align the interests of the Company's Executive Directors and members of the senior management team with those of shareholders by incentivising the delivery of sustained long-term growth in earnings and shareholder value. In addition to t he Options, t he board of directors of EnSilica (the " Board " or the " Directors " ) will continue to grant equity awards to key employees under its broader employee incentive arrangements. The Board believes that broad employee participation in equity incentive schemes helps align employees' interests with those of shareholders and supports the attraction, motivation and retention of skilled talent across the business. Further details of the Options The Options will ordinarily vest following the announcement of the Company's results for the financial year ending 31 May 2029 ("FY2029"), subject to , inter alia, the achievement of demanding performance conditions and continued employment. Where the threshold performance conditions are not achieved at the initial three-year testing date, the Options will remain capable of vesting following the announcement of the Company's results for the financial year ending 31 May 2030 ("FY2030"), subject to the achievement of higher performance targets. Performance will be measured equally against two independent metrics: 1) EBITDA - 50% of the Options are based on adjusted EBITDA targets , whereby 25% of these Options will vest when underlying adjusted EBITDA reaches £10.0 million for FY2029 (increasing to £12.0 million at the FY2030 testing date), with full vesting of these Options requiring adjusted EBITDA of £13.0 million for FY2029 (or £15.0 million for FY2030); and 2) Total Shareholder Return ("TSR") - 50% of the Options are based on TSR targets , measured by reference to the Company's average share price over the 20 trading days from the announcement of the relevant annual results. Vesting will commence as to 25% of these Options only if the average share price reaches 150 pence at the FY2029 testing date (or 172 pence at the FY2030 testing date), with full vesting of these Options requiring an average share price of 200 pence for the FY2029 testing date (or 252 pence for the FY2030 testing date). Between the minimum and maximum performance thresholds, vesting of the Options will occur on a straight-line basis from 25% to 100%. In addition, for any Options that vest and are exercised, 50% of the shares acquired will be subject to a mandatory one-year holding period (net of applicable tax liabilities), further reinforcing the alignment of management's interests with those of shareholders over the longer term. Pursuant to the terms of the LTIP, each Option has an exercise price of 0.1p per share, being the nominal value of the Company's ordinary shares. The Options are subject to the customary provisions of the LTIP, including malus and clawback, leaver provisions and the discretion of the Remuneration Committee in appropriate circumstances. Executive Director Options Of the Options granted, 2,166,000 have been granted to the Executive Directors of the Company as set out below: Name Role Number of new Options granted Number of existing options held Total number of options now held Mark Hodgkins Chairman 393,000 1,515,000 1,908,000 Ian Lankshear Chief Executive Officer 1,212,000 3,015,000 4,227,000 Kristoff Rademan Chief Financial Officer 561,000 128,625 689,625 The table at the end of this announcement, which is provided in accordance with the requirements of the UK Market Abuse Regulation, provides further details. There is n ow a total of 10,188,526 options over new Ordinary Shares granted to directors and employees of the Company. For further information please contact: EnSilica plc Ian Lankshear, Chief Executive Officer Kristoff Rademan, Chief Financial Officer www.ensilica.com via Novella Communications +44 (0)20 3151 7008 Allenby Capital Limited (Nominated Adviser & Joint Broker) Jeremy Porter / Vivek Bhardwaj (Corporate Finance) Joscelin Pinnington / Tony Quirke (Sales & Corporate Broking) +44 (0)20 3328 5656 [email protected] Panmure Liberum Limited (Joint Broker) Edward Mansfield / Will King / Zak Wadud (Corporate Finance) Rupert Dearden / Rauf Munir (Corporate Broking) +44 (0)20 3100 2000 Novella Communications (Investor & Financial Public Relations) Tim Robertson / Oliver Norton +44 (0)20 3151 7008 [email protected] About EnSilica plc EnSilica is a fabless, application-specific chipmaker, combining deep domain and system-level expertise with world-class capability in RF, mmWave, mixed-signal and complex digital IC design. The Company serves customers across the space and communications, industrial, and automotive markets, where safety, security and reliability are critical. A growing portfolio of reusable IP and silicon platforms underpins a repeatable, scalable delivery model, reducing development risk, cost and time to market while supporting long-term supply revenues. EnSilica has a strong track record of delivering production-proven silicon to demanding industry standards. Headquartered near Oxford, UK, the Company operates design centres across the UK, India, Brazil and Hungary. LEI: 213800R6VXRU7MJTAF04 Information required under the UK Market Abuse Regulation: 1 Details of the person discharging managerial responsibilities / person closely associated a) Name Mark Hodgkins Chairman Ian Lankshear Chief Executive Officer Kristoff Rademan Chief Financial Officer 2 Reason for the notification a) Position/status See 1(a) above b) Initial notification /Amendment Initial notification 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name EnSilica plc b) LEI 213800R6VXRU7MJTAF04 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of instrument Identification code Ordinary shares of 0.1p each in EnSilica plc ("Ordinary Shares") ISIN: GB00BN7F1618 b) Nature of the transaction Grant of options over Ordinary Shares under the EnSilica plc Long Term Incentive Plan 2022 c) Price(s) and volume(s) Name Volume Exercise price Mark Hodgkins 393,000 0.1 pence Ian Lankshear 1,212,000 0.1 pence Kristoff Rademan 561,000 0.1 pence d) Aggregated information - Aggregated volume - Price N/A e) Date of the transaction 16 July 2026 f) Place of the transaction Outside of a trading venue